H35.131
Retinopathy of prematurity, stage 2, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinopathy of Prematurity (ROP) is a condition that affects premature infants, involving abnormal growth of blood vessels in the retina — the light-sensitive tissue at the back of the eye. Specifically, stage 2 ROP indicates a moderate level of abnormal blood vessel development. This condition can impact vision if not monitored and addressed properly. The ICD-10 code H35.131 is used to classify this specific diagnosis, focusing on right eye involvement at stage 2.
Causes & Symptoms
Clinical Causes: Premature birth — infants born before 31 weeks gestation are at higher risk. Low birth weight — particularly babies weighing less than 1500 grams. Oxygen therapy — prolonged exposure to high levels of oxygen post-birth can contribute to abnormal vessel growth. Genetic factors — a family history of retinal problems may increase risks. Overall health of the infant — including respiratory issues and unstable health conditions.
Key Symptoms: In most cases, early stages of ROP do not cause noticeable symptoms. If the condition progresses, signs may include: - Abnormal-looking blood vessels in the retina. - Partially or completely detached retina in advanced cases. - Crossed or misaligned eyes (strabismus). - Sudden vision changes or loss of vision in severe cases. - A white appearance in the pupil (leukocoria) or a reduced red reflex during examination.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of stage 2 ROP is made through a comprehensive eye examination, typically performed by an ophthalmologist specialized in pediatric eye care. The process involves dilating the infant's pupils to examine the retina thoroughly, often supplemented with retinal imaging techniques. The eye care professional assesses the extent of abnormal blood vessel growth, the thickness of the retina, and any signs of detachment. Regular screenings are critical for infants at risk, especially those born prematurely or with a low birth weight, to monitor disease progression and determine appropriate management.
Treatment Protocols: Treatment options for retinopathy of prematurity depend on the severity and progression of the disease. For stage 2 ROP, close monitoring is often necessary to observe if the condition stabilizes or advances. When treatment is needed, interventions may include: - Laser therapy — to ablate the abnormal blood vessels and prevent further progression. - Cryotherapy — a freezing technique used in some cases to reduce abnormal vessel growth. - Anti-vascular endothelial growth factor (anti-VEGF) injections — to inhibit abnormal vessel development. - Surgical procedures — such as vitrectomy if retinal detachment occurs. Early detection and timely management are vital to preserve vision and reduce the risk of long-term visual impairment. Long-term follow-up with an eye specialist is essential for infants diagnosed with ROP, even after initial treatment.
Clinical Advice & FAQs
Billing Guidance
Is H35.131 a billable ICD-10 code?
Yes, H35.131 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.131?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 2, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
